Half-dose photodynamic therapy for serous non-neovascular retinal pigment epithelial detachment
Satoru Inoda,1 Hidenori Takahashi,1 Yuji Inoue,1 Hironobu Tampo,1 Shinichi Sakamoto,1 Yusuke Arai,1 Hidetoshi Kawashima,1 Yasuo Yanagi21Ophthalmology, Jichi Medical University, Shimotsuke-Shi, Tochigi, 329-0431, Japan; 2Ophthalmology, Asahikawa Medical University, Asahikawa-Shi, Hokkaido, 078-8510,...
Guardado en:
Autores principales: | Inoda S, Takahashi H, Inoue Y, Tampo H, Sakamoto S, Arai Y, Kawashima H, Yanagi Y |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/64761463e9f64943aa1503d56c0739e9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
GRADED CRITERIA OF DIAGNOSTICS AND PREDICTION OF CENTRAL SEROUS CHORIORETINOPATHY OUTCOME
por: A. G. Shchuko, et al.
Publicado: (2016) -
Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy
por: Dhirani NA, et al.
Publicado: (2017) -
Changes of outer retinal microstructures after photodynamic therapy for chronic central serous chorioretinopathy
por: Shimizu K, et al.
Publicado: (2017) -
Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy
por: Asahi MG, et al.
Publicado: (2017) -
Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion
por: Dogan E, et al.
Publicado: (2018)